SuperworthBicycle Therapeutics shares outstanding BCYC
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 69.8M
- On a year earlier
- +0.8%
- more shares
Bicycle Therapeutics had 69.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 0.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 69.4M | +0% |
| FY2024 | 69.1M | +63% |
| FY2023 | 42.4M | +43% |
| FY2022 | 29.7M | +2% |
| FY2021 | 29M | +38% |
| FY2020 | 21.1M | +17% |
| FY2019 | 17.9M | +3462% |
| FY2018 | 503.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 69.8M | +1% | |
| Q1 FY26 | 69.7M | +1% | |
| Q4 FY25 | 69.4M | +0% | |
| Q3 FY25 | 69.3M | +0% | |
| Q2 FY25 | 69.3M | +33% | |
| Q1 FY25 | 69.2M | +63% | |
| Q4 FY24 | 69.1M | +63% | |
| Q3 FY24 | 69M | +74% | |
| Q2 FY24 | 52M | +72% | |
| Q1 FY24 | 42.6M | +42% | |
| Q4 FY23 | 42.4M | +43% | |
| Q3 FY23 | 39.6M | +33% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Bicycle Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.